Amendment to Schedule 13D for Artelo Biosciences, Inc.

Daniel S. Farb, a reporting person, has filed an amendment to Schedule 13D for Artelo Biosciences, Inc. The amendment updates the ownership details and transactions involving the company's common stock. As of October 20, 2025, Farb ceased to beneficially own more than 5% of the outstanding shares. The amendment includes details of recent transactions, such as the sale of 92,800 shares at $3.9708 per share on October 20, 2025, and the sale of 55,103 shares at $3.5498 per share on October 21, 2025. Farb currently owns 16,399 shares, including 11,299 shares underlying warrants, constituting approximately 0.8% of the outstanding shares. The warrants have an exercise price of $10.00 per share and expire in June 2030.